Axsome Therapeutics, Inc. (AXSM) Reaches $2.49 After 4.00% Down Move; Profile of 1 Analysts Covering The Container Store Group, Inc. (TCS)

April 10, 2018 - By Winifred Garcia

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Logo

Among 8 analysts covering Container Store Group Inc (NYSE:TCS), 1 have Buy rating, 2 Sell and 5 Hold. Therefore 13% are positive. Container Store Group Inc had 12 analyst reports since August 20, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Wednesday, August 30 with “Hold”. The firm has “Hold” rating by Sterne Agee CRT given on Sunday, August 16. The stock has “Neutral” rating by Goldman Sachs on Wednesday, April 6. The firm earned “Neutral” rating on Tuesday, April 26 by Goldman Sachs. The stock has “Underperform” rating by Bank of America on Friday, December 11. The stock of The Container Store Group, Inc. (NYSE:TCS) earned “Neutral” rating by JP Morgan on Friday, January 8. The firm earned “Outperform” rating on Friday, January 8 by Credit Suisse. Morgan Stanley downgraded the stock to “Underweight” rating in Tuesday, January 17 report. The firm has “Neutral” rating given on Thursday, December 17 by Goldman Sachs. The company was upgraded on Thursday, August 20 by BB&T Capital. See The Container Store Group, Inc. (NYSE:TCS) latest ratings:

The stock of Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a huge mover today! The stock increased 1.63% or $0.04 during the last trading session, reaching $2.49. About 78,226 shares traded. Axsome Therapeutics, Inc. (NASDAQ:AXSM) has declined 34.42% since April 10, 2017 and is downtrending. It has underperformed by 45.97% the S&P500.The move comes after 6 months negative chart setup for the $63.48 million company. It was reported on Apr, 10 by Barchart.com. We have $2.39 PT which if reached, will make NASDAQ:AXSM worth $2.54 million less.

Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system disorders. The company has market cap of $63.48 million. The companyÂ’s product candidates include AXS-05 that is in Phase III trial for the treatment of treatment resistant depression and AlzheimerÂ’s disease agitation; and AXS-02, which is in Phase III trial to treat complex regional pain syndrome, knee osteoarthritis related to bone marrow lesions, and chronic low back pain related to Modic changes. It currently has negative earnings. It is also developing AXS-06, a preclinical product candidate for CNS disorders, including chronic pain.

Among 3 analysts covering Axsome Therapeutics (NASDAQ:AXSM), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Axsome Therapeutics had 3 analyst reports since December 14, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, December 14 by Ladenburg Thalmann. On Monday, October 3 the stock rating was initiated by Brean Capital with “Buy”. The company was initiated on Tuesday, December 15 by Cantor Fitzgerald.

The Container Store Group, Inc. engages in the retailing of storage and organization products and solutions in the United States. The company has market cap of $280.79 million. The firm operates through two divisions, The Container Store and Elfa. It has a 10.02 P/E ratio. The Company’s retail stores provide various lifestyle products, including bath, box, closets, collections, containers, gift packaging, hooks, kitchen, laundry, office, shelving, storage, trash, and travel, as well as elfa branded products.

Investors sentiment increased to 1.65 in Q4 2017. Its up 0.27, from 1.38 in 2017Q3. It increased, as 8 investors sold The Container Store Group, Inc. shares while 18 reduced holdings. 17 funds opened positions while 26 raised stakes. 37.90 million shares or 1.65% more from 37.28 million shares in 2017Q3 were reported. Schwab Charles Mgmt holds 79,435 shares. Blair William Co Il has invested 0% of its portfolio in The Container Store Group, Inc. (NYSE:TCS). Janney Montgomery Scott Limited Liability accumulated 17,300 shares or 0% of the stock. Winch Advisory Services Limited Liability Co has invested 0% in The Container Store Group, Inc. (NYSE:TCS). Rhumbline Advisers owns 15,763 shares or 0% of their US portfolio. The New York-based Morgan Stanley has invested 0% in The Container Store Group, Inc. (NYSE:TCS). First Tru Advsrs L P owns 15,562 shares. Indexiq Limited Liability Com invested in 333,029 shares or 0.06% of the stock. Stratos Wealth Prtn reported 0% stake. 36,965 are held by Bancorporation Of America Corp De. Northern accumulated 169,321 shares. Virtu Financial Limited Liability Com has 35,480 shares. 275,928 were reported by State Street. Stone Ridge Asset Mgmt Ltd Co reported 37,394 shares or 0.01% of all its holdings. New York-based Blackrock has invested 0% in The Container Store Group, Inc. (NYSE:TCS).

The stock increased 3.94% or $0.22 during the last trading session, reaching $5.81. About 52,407 shares traded. The Container Store Group, Inc. (NYSE:TCS) has risen 40.66% since April 10, 2017 and is uptrending. It has outperformed by 29.11% the S&P500.

The Container Store Group, Inc. (NYSE:TCS) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>